Molecular Diagnostics Market Comprehensive Survey by 2023 with Top Key Manufacture Roche, Abbott, Myriad Genetics, QIAGEN, Cepheid, BD, and bioMérieux

The Global Molecular Diagnostics Market is projected to reach more than US$ 30 Billion from 2016 to 2021.

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing.

The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market

The Market Share Of The Largest Companies Accounted Of Global Market, Which Are:

• Roche

• Abbott Laboratories

• Myriad Genetics

• Qiagen

• Cephied

• Becton Dickinson

• Biomerieux

• Other Companies

Request Free Sample to Get a Complete List of Companies

Get Free Sample Report @ https://www.researchformarkets.com/sample/molecular-diagnostics-market-412

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India are expected to show high growth rates in the next six years in molecular diagnostics market.

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment. Oncology test controls nearly 25% market share by the year 2021.

Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.

In terms of technology, Biochips/Microarrays are the fastest growing segment and are expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

The following application segments of the molecular diagnostics market are detailed with size and six year forecast.

• Infectious Disease Testing

• Cardiovascular Disease Testing

• Oncology Testing

• Neurological Disorders Testing

• Food Pathogen Detection Testing

• Genetic Testing

• Blood Screening

• Tissue Typing (HLA Testing)

• Others Molecular Testing

Furthermore, the following technology segments of the molecular diagnostics market are detailed with size and six year forecast.

• PCR Based Test

• PCR Related Technologies

• Non–PCR Test

• Fish & Innovations Testing

• Biochips/Microarrays

• Biosensors

• Molecular Imaging

• Other Technologies

To Know More Details about Molecular Diagnostics Market @ https://www.researchformarkets.com/reports/molecular-diagnostics-market-412

Table of Contents

Part 1. Exclusive Summary

Part 2. Methodology

Part 3. Introduction

Part 4. Competitive Landscape

Part 5. Market Dynamics

Part 6. Segmentation by Application

Part 7. Supply by Region

Part 8. Consumption Pattern

Part 9. Market Forecast

Part 10. Key Vendors

Part 11. Industry Activity

Part 12. Appendix

For Instant Discount @ https://www.researchformarkets.com/discount/molecular-diagnostics-market-412

Global Molecular Diagnostics Market has been analyzed from 6 viewpoints:

1) Market and Forecast

2) Application Wise Market & Forecast

3) Geographical Market & Forecast

4) Technology Wise Market & Forecast

5) Company Wise Molecular Diagnostics sales & Forecast

6) Market Growth Drivers & Challenges

Research You Can Trust:

These reports are written by our research team, a dedicated group of analysts that knows the industry inside and out.

Data Sources

The information contained in this report is based on secondary sources.

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. Research team seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources.

Inquiry Before Buying @ https://www.researchformarkets.com/inquiry/molecular-diagnostics-market-412

About Research for Markets:
Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Contact:
Mr. A Naidu
Research for Markets
Tel: +44 8000-4182-37 (UK)
Email: alan.naidu@researchformarkets.com

This release was published on openPR.